Breaking News

NEW YORK, Aug. 20 – Paradigm Genetics has developed a microarray for the rice pathogen Magnaporthe grisea, the company said on Monday.

NEW YORK, Aug.

NEW YORK, August 17 – GeneProt has appointed Bertrand Damour chief financial officer, Stephen Macevicz, vice president of intellectual property, and Diana Wetmore chief technical officer for the Geneva branch, the company announced on Friday.

We all have expectations: warm, sunny weather in the summer, snow in the winter. But as we all know, sometimes what we expect is not what we get, and we are forced to deal with scorching heat in July and blizzards in January.

NEW YORK, Aug 16 – Orchid BioSciences said Thursday it had received approval to provide its cystic fibrosis genetic screening test to certain approved labs in the United States. The Elucigene CF 29 test screens for 29 common mutations a

NEW YORK, Aug. 16 – Genomic firm Hyseq and the pharmaceutical division of Japanese brewer Kirin have signed a three-year collaboration to discover proteins and antibodies for a variety of diseases, the firms said on Thursday.

NEW YORK, Aug 16 – NeoGenesis Drug Discovery has announced a deal to work with Mitsubishi-Tokyo Pharmaceuticals to identify small-molecule drug candidates.  Under the terms of the deal, NeoGenesis of Cambridge, Mass., will use its

NEW YORK, Aug 16 – Canadian life science company MDS has agreed to develop and commercialize Signature BioScience's microwave spectroscopy instrumentation, the companies announced. MDS will pay Signature Biosciences $10 million upfront

NEW YORK, Aug 16.

NEW YORK, Aug 15 – Scientists at Monsanto and researchers at the University of Richmond, Virginia, have released the genome sequence for Agrobacterium tumefaciens , a bacterium that transfers DNA to plant cells. "Agrobacterium t

NEW YORK, Aug 15 – DeCode of Reykjavik, Iceland reported a 62 percent increase in second-quarter revenues, which rose to $6.2 million, compared with $3.8 million in the year ago period, as the company received increased milestone payments from its drug discovery colla

NEW YORK, Aug 15 – A new study of the proteomics market forecast that the proteomics market would grow nearly six-fold to $5.6 billion by 2006 from $963 million in 2000. In its report, consultancy firm Frost & Sullivan said the incr

NEW YORK, Aug 15 - GlaxoSmithKline has agreed to a multi-year, non-exclusive sublicense to Lexicon Genetic’s gene targeting technologies, Lexicon said Wednesday. The deal brings the total number of licensees for the technologies to 15.

NEW YORK, Aug.

NEW YORK, Aug. 15 – Motorola Life Sciences introduced its high-density human genome bioarray on Wednesday as part of its CodeLink bioarray systems launch.

NEW YORK, Aug 15 – In a move signaling Human Genome Sciences’ intentions to expand its business, the company has appointed Ellen Baron to the position of senior vice president, business development. In her new role, Baron, who was previ

NEW YORK, Aug 14 – Eksigent Technologies has announced that it has licensed Sandia National Laboratories’ microfluidics technology. Eksigent and Sandia, both of Livermore, Calif., did not disclose the terms of the deal or describe the s

NEW YORK, Aug 14 – Exelixis of South San Francisco, Calif., has announced an agreement with Elan Pharmaceuticals to develop a compound library, marking Exelixis’ initial chemistry deal.

NEW YORK, Aug 14 – Incyte and the Guy's and St.

Pages

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.